1991 ~ 1998 B.S., Animal Science, Seoul National University
1998 ~ 2000 M.S., Reproductive Physiology, Seoul National University
2005 ~ 2009 Ph.D., Reproductive Physiology and Regenerative Biology, University of Connecticut, USA
Professional Career
2000 ~ 2012 Drug Development Center, LG Life Sciences R&D Park
- Phase 1 IND approval of LC28-0126, a first-in-class NCE against acute myocardial infarction
- Preclinical R&D and NDA approval of Zemiglo, a DPP4 inhibitor for T2D
- GLP certificate of developmental and reproductive toxicity study
2013 ~ 2016 Institute of Drug Discovery, LG Life Sciences R&D Park
- PI, new drug program of metabolic disorders
- PI, Korean colon cancer genomics
- PI, Knowledge-based therapeutic target ID in metabolic disorders
2018 ~ 2019 Academic Chair, The Korea Society of Non-clinical Study
2020 ~ 2022 Director, DATRI, GBST
2022 ~ 2023 Vice President, The Korea Society of Non-clinical Study
